 |
| SEPTEMBER
8, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
 |
BIG4BIO
CEO WEEKLY Q&A:
CONTINUING NEXT WEEK! |
| Due to
the Labor Day holiday, we will have our
next CEO Q&A next week with
Manish Arora, Founder and CEO,
LinusBio - check out our
previous Q&As here.
|
|
|
- Applied
BioCode: Distribution Agreement With Henry
Schein More
- Ark
Clinical Research: Joins Genentech's Advancing
Inclusive Research Site Alliance More
- PeproMene
Bio: Publication in The Lancet of
Breakthrough Phase 1 Clinical Trial Results
Demonstrating Deep and Durable Complete
Responses in Relapsed/Refractory B-cell
Lymphomas, Including After Prior CD19 CAR
T-cell Failure More
- SinglePass:
Device Achieves 100% Technical Success and
Zero Clinically Significant Bleeding Events in
Multicenter Study Published in the Journal of
Vascular and Interventional Radiology More
- Tarsus
Pharmaceuticals: Completes Acquisition of
Alkeus Pharmaceuticals, Expanding Leadership
in Eye Care More
- UCLA
Health: AI May Help Identify Breast Cancers
Missed by Mammograms, but Clinical Benefit
Remains Uncertain More
- UCLA
Health: Expert Weighs In on New Treatment
Approach for Children With Short-Limbed
Dwarfism More
- UCLA
Health: How the Developing Human Brain Takes
Instructions - Two Studies Reveal What Guides
Its Most Important Stem Cells More
- UCLA
Health: Study Identifies Stress-Response
Cells, Points to New Treatment Target More
|
|
- Arcutis
Biotherapeutics: Inducement Grants Under
Nasdaq Listing Rule 5635(c)(4) More
- Cancer
R&D Partnerships, M&A, Venture Funding
and IPO Activity – Q2 2026 Review More
- Health
Tech Investors Are Looking at Bigger Bets More*
- Latigo
Biotherapeutics: Second Quarter 2026 Financial
Results and Recent Business Highlights More
- mPulse:
Expands Connected Platform and National
Capacity in Q2 2026 More
- Puma
Biotechnology: Inducement Awards Under Nasdaq
Listing Rule 5635(c)(4) More
- September
5, 2026: BioPharmCatalyst Weekly Watchlist:
Key Catalysts Left for the Quarter More
|
|
- BioPharmGuy News: Slicing Blind, Gut Breath,
Team Roast - 80s Reboot, Website Commentary More
- Biotech & Pharma Updates | September 3,
2026 More
- Biotech & Pharma Updates | September 4,
2026 More
- Cedars Sinai: Medscape - STI Rates Fall
After DoxyPEP More
- ESC: Amgen CMO Flags Repatha 'Inflection'
Amid New Data on Mortality Benefit More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
-
|
| Life
Sciences Talent and Consulting
Strategist George Quinn Named
Partner, Fractional Talent at
Slone Partners |
|
Learn More
→ |
|
|
- Chutes & Ladders—Invivyd’s Chairman Adds
CEO Role Ahead of COVID Readout More
- Fierce Biotech Layoff Tracker 2026: Novartis
Nixes Swiss Site; TScan Telegraphs 75%
Headcount Drop More
- OPPORTUNITY: Head of Global Research &
Development - Columbia, MD More
- OPPORTUNITY: Head of Marketing &
Communications - Remote More
- OPPORTUNITY: Vice President, Business
Development - Remote More
- Slone Partners: Behind the
Search’: A Conversation with George Quinn,
Partner, Fractional Talent More
- Slone Partners: Fractional
Leadership in Biotech and Life Sciences:
When it Works and Why More
- Slone Partners: ICYMI - How to Keep Your
Highest Performers Engaged More
- UCLA Health: Nuclear Medicine
Physician-Scientist Dr. Amir Iravani Joins
to Lead Theranostics Program More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Los Angeles Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Los
Angeles, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
